November 19, 2025- Thermo Fisher Scientific Inc. announced the grand opening of its East Coast flagship Advanced Therapies Collaboration Center (ATxCC) in Philadelphia, marking the company’s second ATxCC in the United States following the opening of its Carlsbad, California, site. Together, these centers expand the company’s nationwide network supporting cell and gene therapy (CGT) innovation, providing critical resources to biotech, biopharma and translational researchers developing next-generation cell-based immunotherapies.
Advanced therapies represent one of the most promising frontiers in modern medicine, offering the potential to treat, and even cure, diseases once considered untreatable. As demand for these therapies grows, so does the need for scalable, innovative solutions. The opening of Thermo Fisher’s new East Coast center highlights the company’s ongoing investment in enabling these breakthroughs and advancing the future of healthcare.